Results 21 to 30 of about 279,219 (179)

Fluconazole prophylaxis in preterm infants: a systematic review

open access: yesBrazilian Journal of Infectious Diseases, 2017
Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis.
Juliana Ferreira da Silva Rios   +3 more
doaj   +2 more sources

Shifting Paradigms in Antifungal Prophylaxis and Their Effects on Candidemia Outcomes in Hematological Malignancies: A 14-Year Experience from a Single Tertiary Center [PDF]

open access: yesJournal of Fungi
Evolving antifungal prophylaxis approaches have reshaped candidemia patterns and outcomes in hematological malignancy (HM) patients. This study aimed to evaluate temporal changes in candidemia incidence, species distribution, and factors associated with ...
Fazıl Çağrı Hunutlu   +11 more
doaj   +2 more sources

Antifungal Prophylaxis Utilization and the Associated Clinical Outcomes Among Pediatric Patients with Hematological Malignancies or Undergoing Hematopoietic Stem Cell Transplantation [PDF]

open access: yesJ Clin Med
Background/Objectives: Invasive fungal infections (IFIs) are a prevalent complication of intensive chemotherapy and hematopoietic stem cell transplantation (HSCT) in the pediatric population and are associated with high morbidity and mortality.
Juhaina Salim Al-Maqbali   +4 more
core   +2 more sources

Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants [PDF]

open access: yesInternational Journal of Pediatrics, 2009
We conducted a retrospective case series study to evaluate the safety of fosfluconazole prophylaxis for preventing invasive fungal infection in VLBW infants with a central vascular access.
Daijiro Takahashi   +7 more
doaj   +2 more sources

Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study [PDF]

open access: yesFrontiers in Oncology
IntroductionOur monocentric and retrospective study aimed to investigate the clinical effectivity of HEPA filters in combination with the antifungal drug prophylaxis in patients with AML undergoing intensive chemotherapy and allogeneic stem cell ...
Linda Preyer   +14 more
doaj   +2 more sources

PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia [PDF]

open access: yes, 2022
Mould-active antifungal prophylaxis is frequently used to prevent invasive fungal infection in patients with acute leukaemia being treated with intensive chemotherapy.
Allsup, David   +5 more
core   +1 more source

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Current antifungal prophylaxis policies and practices in UK NICUs [PDF]

open access: yes
Background: Invasive fungal infections cause significant mortality and morbidity in the neonatal intensive care unit (NICU). In 2021, the National Institute for Health and Care Excellence (NICE) recommended the use of antifungals to prevent fungal ...
Kantyka, Carla   +3 more
core   +4 more sources

Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis

open access: yesFrontiers in Immunology, 2023
CAR-T therapy has revolutionized the treatment of relapsed/refractory B-cell malignancies. Patients who are receiving such therapy are susceptible to an increased incidence of infections due to post-treatment immunosuppression.
Elsa Pennese   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy